View in EDS HTML Full Text PDF Full Text

Comparative safety and effectiveness of vedolizumab to tumour necrosis factor antagonist therapy for Crohn's disease.

Saved in:
Bibliographic Details
Title: Comparative safety and effectiveness of vedolizumab to tumour necrosis factor antagonist therapy for Crohn's disease.
Authors: Bohm, Matthew1 (AUTHOR), Xu, Ronghui2 (AUTHOR), Zhang, Yiran2 (AUTHOR), Varma, Sashidhar1 (AUTHOR), Fischer, Monika1 (AUTHOR), Kochhar, Gursimran3 (AUTHOR), Boland, Brigid2 (AUTHOR), Singh, Siddharth2 (AUTHOR), Hirten, Robert4 (AUTHOR), Ungaro, Ryan4 (AUTHOR), Shmidt, Eugenia5 (AUTHOR), Lasch, Karen6 (AUTHOR), Jairaith, Vipul7 (AUTHOR), Hudesman, David4 (AUTHOR), Chang, Shannon4 (AUTHOR), Lukin, Dana4 (AUTHOR), Swaminath, Arun4 (AUTHOR), Sands, Bruce E.4 (AUTHOR), Colombel, Jean‐Frederic4 (AUTHOR), Kane, Sunanda8 (AUTHOR)
Source: Alimentary Pharmacology & Therapeutics. Aug2020, Vol. 52 Issue 4, p669-681. 13p. 1 Diagram, 4 Charts, 2 Graphs.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:02692813
DOI:10.1111/apt.15921